Dexmetomedine for Post Operative Delirium in Elderly Patients Undergoing Elective Total Knee Replacement Under Spinal Anesthesia

NCT ID: NCT05707741

Last Updated: 2024-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-01

Study Completion Date

2024-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative delirium is a geriatric syndrome occurring after anesthesia and surgery which manifests as acute alterations in mental status, involving changes in cognition, attention, and levels of consciousness that tend to fluctuate The use of dexmedetomidine with the intention to prevent postoperative delirium remains controversial. Where it has shown to be effective in older adult patients undergoing cardiovascular and non-cardiovascular surgeries

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On the day of surgery and after arrival to the theatre, all patients will have supplemental oxygen by nasal cannula at 5 L min-1 and will be connected to the standard monitoring non-invasive blood pressure, electrocardiography, and pulse oximetry. crystalloid 10mg/kg will be administered then all patients will receive spinal anaesthesia in the sitting position, under complete aseptic technique. The midline or Para median spinal puncture will be performed. volume of 3 ml of hyperbaric bupivacaine (Marcaine® Spinal Heavy 0.5%, AstraZeneca) will be injected using a 25 G spinal needle . After establishment of spinal anesthesia , A loading dose of dexmetomedine (1 µg/kg) will be administered for 10 min for all the patients then Three types of syringes will be prepared on 50 ml syringes Group A: saline 50 ml, Group B: a 50 ml mixture of saline 49 ml and dexmedetomidine 100 μg, and Group C: a 50 ml mixture of saline 48 ml and dexmedetomidine 200 μg. the patients then they will be randomized into 3 groups

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

prospective randomized trial
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

normal saline infusion rate 0.4uq/kg /hour

Group Type PLACEBO_COMPARATOR

dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,

Dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 48 ml and dexmedetomidine 200 μg

Group B

dexmetomedine 0.2 µg/kg/hr

Group Type ACTIVE_COMPARATOR

dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,

Dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 48 ml and dexmedetomidine 200 μg

Group C

dexmetomedine 0.4 µg/kg/hr

Group Type ACTIVE_COMPARATOR

dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,

Dexmetomedine infusion

Intervention Type DRUG

50 ml mixture of saline 48 ml and dexmedetomidine 200 μg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dexmetomedine infusion

50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,

Intervention Type DRUG

Dexmetomedine infusion

50 ml mixture of saline 48 ml and dexmedetomidine 200 μg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status I- II
* Age from 65to 75 years old,
* Elective total knee arthroplasty under spinal anaesthesia.

Exclusion Criteria

* Bleeding disorders
* Allergy to any of the drugs used in the study
* Renal insufficiency
* Liver failure-Neurological abnormalities -patients with hearing and visual impairment
Minimum Eligible Age

65 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Menoufia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

rabab Mohammad habeeb

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

rabab M habeeb, Dr

Role: PRINCIPAL_INVESTIGATOR

Menoufia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Menoufia University

Menoufia, Menoufia, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1/2023,ANET2-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexmedetomidine Effect on Delirium of Elderly Patients
NCT06111300 NOT_YET_RECRUITING PHASE4